Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Alopecia areata patients often face mental health issues like anxiety and depression.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.

Healthier hair and scalp improve mental wellbeing.

Alopecia negatively affects quality of life and mental health.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

People with rheumatoid arthritis have poorer sleep quality than healthy individuals.

Standardized forms and digital tools can improve alopecia biopsy diagnosis.

The facial aging scale is a reliable tool for assessing skin aging and treatment effects.

Low self-esteem and self-worth in teens increase the risk of delinquent behavior.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Individualized homeopathic treatment may help improve hair loss and well-being in people with alopecia areata.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Nail changes are common in alopecia areata and can indicate its severity.

Androgenic alopecia affects men's quality of life more than women's.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.